Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4

Direct-acting antiviral drugs to cure infections with Hepatitis C virus (HCV) achieve a sustained virological response (SVR) in more than 90% of adult patients. At present, clinical trials are ongoing and real-life data are still limited in children. Herein, we report two cases of pediatric patients...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Nadia Marascio, Maria Mazzitelli, Grazia Pavia, Aida Giancotti, Giorgio Settimo Barreca, Chiara Costa, Vincenzo Pisani, Giuseppe Greco, Francesca Serapide, Enrico Maria Trecarichi, Francesco Casalinuovo, Maria Carla Liberto, Giovanni Matera, Carlo Torti
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2019-05-01
Ráidu:	Cells
Fáttát:	pediatric patients Hepatitis C virus 4 sofosbuvir/ledipasvir
Liŋkkat:	https://www.mdpi.com/2073-4409/8/5/416
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!